Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             14 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adjuvant versus salvage radiotherapy: debates will be reignited Spratt, D.E.

35 7 p. 585-587
artikel
2 Antibody–drug conjugates in lung and breast cancer: current evidence and future directions—a position statement from the ETOP IBCSG Partners Foundation Peters, S.

35 7 p. 607-629
artikel
3 Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes Tarantino, P.

35 7 p. 579-581
artikel
4 Defining the subset of mutations in polymerase epsilon (POLE) associated with loss-of-proofreading (LOP) functionality Maddalena, G.

35 7 p. 678-680
artikel
5 Editorial Board
35 7 p. iii
artikel
6 Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer Ambrosini, M.

35 7 p. 643-655
artikel
7 IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer Dent, R.

35 7 p. 630-642
artikel
8 MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy Pignata, S.

35 7 p. 667-676
artikel
9 Overcoming barriers in biomarker testing. Letter to the Editor regarding: ‘ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe’, by A. Bayle et al. García-Foncillas, J.

35 7 p. 677-678
artikel
10 Proofreading the way: immune checkpoint inhibitors in polymerase ε/polymerase δ (POLE/POLD1)-altered colorectal cancer Cecchini, M.

35 7 p. 582-584
artikel
11 Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group Mosele, M.F.

35 7 p. 588-606
artikel
12 Table of Contents
35 7 p. i-ii
artikel
13 Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047) Parker, C.C.

35 7 p. 656-666
artikel
14 VP4-2024: First-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients (pts) with advanced solid tumors: First-in-human phase I study Bai, X.

35 7 p. 681-682
artikel
                             14 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland